Barclays keeps Overweight on ProPetro and Stryker but cuts price targets
Barclays kept Overweight ratings on ProPetro Holding and Stryker while lowering both price targets. The data was published by TradingView, citing Benzinga.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Barclays kept its Overweight rating on ProPetro Holding but cut its price target from $17 to $15, a reduction of 11.8%. According to TradingView, the stock closed at $7.87 on October 29. The same report lists recent notes from other brokers: Morgan Stanley kept its Equal-Weight rating with a $12 target, and Citigroup kept its Buy rating with a $14.50 target.
On the same day, Barclays kept its Overweight rating on Stryker and lowered its price target from $375 to $365, a 2.7% decrease. The stock closed at $311.75 on October 29. Per Benzinga, Stryker had five analyst notes over the past 30 days, with targets ranging from $300 to $390. Canaccord Genuity downgraded the stock to Hold with a $300 target.
why it matters
Price target changes like these are routine and rarely move the broader market. They reflect individual analysts revising their estimates for specific companies rather than any decision by the companies themselves. The information from Benzinga is not investment advice.
tags
instruments
sources
- Barclays maintains ProPetro Holding at Overweight, lowers price target to $15 from $17 — TradingView, 30 October 2026 at 15:11 UTC
- Barclays maintains Stryker at Overweight, lowers price target to $365 from $375 — TradingView, 30 October 2026 at 15:16 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗